Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Developmental estrogenization and prostatic neoplasia

R Santti1, R R Newbold, S Mäkelä

  • 1Department of Anatomy, University of Turku, Finland.

The Prostate
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of nicotine products and withdrawal support among personnel of the Finnish Defence Forces.

BMJ military health·2025
Same author

The presence of intraperitoneal, retroperitoneal and pleural fluid in acute Puumala hantavirus infection.

Infectious diseases (London, England)·2022
Same author

Pragmatic diagnostic and therapeutic algorithms to optimize new potassium binder use in cardiorenal disease.

Pharmacological research·2022
Same author

Corrigendum to "Celiac disease or positive tissue transglutaminase antibodies in patients undergoing renal biopsies" [Dig Liver Dis (2018);50:27-31].

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2019
Same author

Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2019
Same author

Internet as a source of medicines information (MI) among frequent internet users.

Research in social & administrative pharmacy : RSAP·2017
Same journal

Salvage Androgen Deprivation Therapy Use After Definitive Radiotherapy With vs Without Androgen Deprivation Therapy in Prostate Cancer.

The Prostate·2026
Same journal

A Simple Cell Culture Assay for Human Prostatic Branching Morphogenesis Spotlights Bone Morphogenetic Protein Signaling as a Therapeutic Target in Benign Prostatic Hyperplasia.

The Prostate·2026
Same journal

Temporal Trends of Metastatic Prostate Cancer in the Prostate-Specific Membrane Antigen Positron Emission Tomography Era in the United States.

The Prostate·2026
Same journal

Holmium Laser Enucleation of the Prostate (HoLEP) With Proactive Preservation of One Lateral Lobe: A Technique for Benign Prostatic Hyperplasia to Preserve Sexual Function.

The Prostate·2026
Same journal

Clinical Variable-Based Machine Learning for Predicting Early mCRPC Using Exclusively Clinical Variables: Development and Multicenter External Validation.

The Prostate·2026
Same journal

Association Between Intraoperative Prostate Bed Blood Flow and Postoperative Lower Urinary Tract Symptoms After Robot-Assisted Radical Prostatectomy.

The Prostate·2026
See all related articles

Estrogen exposure during development may predispose the prostate for later diseases like benign prostatic hyperplasia and cancer. Critical estrogen action occurs during prostate development, potentially creating sensitive cells.

Area of Science:

  • Endocrinology
  • Urology
  • Developmental Biology

Background:

  • The role of estrogens in benign prostatic hyperplasia (BPH) and prostate cancer is debated, with no conclusive evidence.
  • Previous studies have explored correlations between estrogens and prostate alterations in humans and animal models.

Purpose of the Study:

  • To review existing literature on estrogens and prostatic disease.
  • To propose an alternative role for estrogens as a predisposing factor for prostatic diseases, particularly focusing on developmental exposure.

Main Methods:

  • Literature review of studies investigating estrogens and prostate health.
  • Utilizing a developmentally estrogenized mouse model to study long-term effects.

Main Results:

Related Experiment Videos

  • Estrogen exposure during development may initiate cellular changes in the prostate.
  • These changes may predispose the prostate to hyperplasia or neoplasia later in life, requiring subsequent estrogen and/or androgen signaling.

Conclusions:

  • The critical window for estrogen's influence on prostatic disease risk is during early development.
  • Estrogen-sensitive cells may persist, leading to increased responsiveness to hormones and altered growth control later in life.